Transforming promising molecules into valued medicines – the emerging Alderley Park Translational Science Ecosytem (APTrans)

Transforming promising molecules into valued medicines – the emerging Alderley Park Translational Science Ecosytem (APTrans)

Design space considerations for dissolution methods

Accelerating the development of drug products using advanced pharmaceutical design tools and manufacturing

Pharmaceutical Quality: The dissolution test and clinically relevant specifications – impact on product development

Clinically relevant specifications in practice: What have we learned since the QbD Pilot Program?

Introduction to the Biopharmaceutics Risk Assessment Roadmap (BioRAM), Drug Delivery Scenarios and Scoring Grid

Score sheet, Box 1: Early basic knowledge, starting point.  From Blueprint to action: Getting to critical questions and knowledge.

In silico modelling: Subcutaneous Bioavailability of mAbs

Biopharmaceutics in Complex Parenteral Formulation Design

Early understanding of PK/PD: setting up success in development?

It’s never too early to put the patient first

Streamlined pathways to clinical success through integrated modelling